Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.
Speaker Jacob Allan Udell
Congress : ESC Congress 2018
- Topic : preventive cardiology
- Sub-topic : Diabetes and the Heart
- Session type : Satellite Symposium
- FP Number : 513
- Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance